The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 2 May 2006, www.theannals.com, DOI 10.1345/aph.1G226.
The Annals of Pharmacotherapy: Vol. 40, No. 5, pp. 836-849. DOI 10.1345/aph.1G226
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whelan, A. M.
Right arrow Articles by Bowles, S. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whelan, A. M.
Right arrow Articles by Bowles, S. K

COMPLEMENTARY AND ALTERNATIVE MEDICINE

Natural Health Products in the Prevention and Treatment of Osteoporosis: Systematic Review of Randomized Controlled Trials

Anne Marie Whelan, PharmD

Associate Professor, College of Pharmacy, Dalhousie University, Halifax, NS, Canada; Pharmacy Consultant, Department of Family Medicine, Dalhousie University

Tannis M Jurgens, PhD

Assistant Professor, College of Pharmacy, Dalhousie University

Susan K Bowles, PharmD

Associate Professor, College of Pharmacy and Division of Geriatric Medicine, Dalhousie University; Clinical Pharmacy Specialist-Geriatrics, Centre for Health Care of the Elderly, Division of Geriatric Medicine and Department of Pharmacy, Capital District Health Authority

Reprints: Dr. Whelan, College of Pharmacy, Dalhousie University, 5968 College St., Halifax, NS B3H 3J5, Canada, fax 902/494-1396, Anne.Marie.Whelan{at}Dal.Ca

BACKGROUND: Consumers are increasingly looking to natural health products to manage specific diseases such as osteoporosis. As a result, healthcare providers need evidence-based information on which to base recommendations regarding use and efficacy.

OBJECTIVE: To identify natural health products (NHPs, ie, dietary supplements) advocated for the prevention and treatment of osteoporosis and systematically review the evidence from randomized controlled trials for the effect of NHPs on bone mineral density (BMD)/fracture rate in women.

METHODS:MEDLINE, Natural Medicines Comprehensive Database, and the Internet were initially searched to identify NHPs advocated for prevention and treatment of osteoporosis. For NHPs having evidence to support their claim, the aforementioned sources, along with International Pharmaceutical Abstracts, the Cochrane Library, the International Bibliographic Information on Dietary Supplements, the Cumulative Index to Nursing & Allied Health, and HerbMed, were searched to locate randomized controlled trials published in English between 1966 and October 2004. Bibliographies of identified articles were also searched. Randomized controlled trials were selected if they evaluated the use of a single NHP in women, using BMD/fracture rate as the outcome measure. NHPs were excluded from further evaluation if a review had already been published. Data were extracted using predetermined criteria and studies appraised using the Jadad scale. Forty-five NHPs were identified that the authors claimed to be beneficial in prevention and treatment of osteoporosis, with 15 having evidence to support their claim. Calcium; copper; evening primrose oil; fish oils; fluoride; magnesium; manganese; strontium; vitamin D; and black, green, and oolong tea did not meet study criteria.

RESULTS: Results from randomized controlled trials evaluating dehydroepiandrosterone (DHEA), phytoestrogens, and vitamin K2 (menaquinone or menatetrenone) were promising; however, study limitations suggest the need for confirmatory evidence.

CONCLUSIONS: Although no definitive conclusions can be drawn, the relative safety of phytoestrogens, DHEA, and vitamin K2 at the studied doses, as well as preliminary positive results from randomized controlled trials, provides some initial support for the use of these NHPs in the prevention and treatment of osteoporosis in women.

Key Words: DHEA, dietary supplements, natural health products, osteoporosis, phytoestrogens, vitamin K2

Published Online, May 2, 2006. www.theannals.com, DOI 10.1345/aph.1G226


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
A. M. Whelan, T. M Jurgens, S. K Bowles, and H. Doyle
Efficacy of Natural Health Products in Treating Osteoporosis: What is the Quality of Internet Patient Advice?
Ann. Pharmacother., May 1, 2009; 43(5): 899 - 907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
A. Devine, J. M Hodgson, I. M Dick, and R. L Prince
Tea drinking is associated with benefits on bone density in older women
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1243 - 1247.
[Abstract] [Full Text] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.